Tianjin Medical University Cancer Institute and Hospital
In research, Tianjin Medical University Cancer Institute and Hospital stands highest in Medicine (#788 of 10,443 worldwide), Oncology (#64 of 772 worldwide) and Life Sciences (#651 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Cancer Research, Oncology and Hepatology — Cancer Research is 17.2× its share of world research.
- World rank, 2022–2025
- #1,684 of 28,054 · #3,789 all time
- Rank in China
- #474 of 3,058
- Research works
- 6k ▲ 17% vs 2013–17
- Citations
- 101k 16.9 per fractional work
- Top-10% rate
- 22.8% record average 16.5%
- Open access
- 50% world 28%
What is Tianjin Medical University Cancer Institute and Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #788 of 10,443 | 20.9% | 1,054 | #1512 | |
| OncologySubfield | #64 of 772 | 23.0% | 289 | #290 | |
| Life SciencesDomain | #651 of 7,800 | 25.8% | 533 | #1610 | |
| Health SciencesDomain | #1,173 of 11,982 | 21.0% | 1,066 | #1984 | |
| Pulmonary and Respiratory MedicineSubfield | #169 of 1,144 | 18.8% | 221 | #527 | |
| Molecular BiologySubfield | #454 of 2,175 | 24.7% | 242 | #1169 | |
| Biochemistry, Genetics and Molecular BiologyField | #822 of 3,579 | 25.0% | 424 | #1867 | |
| Cancer ResearchSubfield | #72 of 237 | 24.7% | 127 | #177 | |
| SurgerySubfield | #611 of 1,816 | 20.9% | 111 | #1382 | |
| Immunology and MicrobiologyField | #317 of 682 | 28.2% | 84 | #817 |
Each strip is that field’s whole ranked pool, with the notch where Tianjin Medical University Cancer Institute and Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#1,512 #788
- Oncology#290 #64
- Life Sciences#1,610 #651
- Health Sciences#1,984 #1,173
- Pulmonary and Respiratory Medicine#527 #169
- Molecular Biology#1,169 #454
- Biochemistry, Genetics and Molecular Biology#1,867 #822
- Cancer Research#177 #72
- Surgery#1,382 #611
- Immunology and Microbiology#817 #317
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Tianjin Medical University Cancer Institute and Hospital specialise in?
Where its research is concentrated relative to its size: Cancer Research takes 17.2× the share of its output that it takes of world research.
- Cancer ResearchSubfield · 127.1 works17×
- OncologySubfield · 289.4 works15×
- HepatologySubfield · 35.6 works11×
- Pulmonary and Respiratory MedicineSubfield · 221.0 works8.4×
- Pathology and Forensic MedicineSubfield · 66.3 works7.5×
- ImmunologySubfield · 81.6 works7.0×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.9×. Every wedge is a field page.
- Immunology and Microbiology 4.9×
- Biochemistry, Genetics and Molecular Biology 4.7×
- Medicine 3.2×
- Neuroscience 0.7×
- Pharmacology, Toxicology and Pharmaceutics 0.5×
- Nursing 0.4×
- Chemistry 0.3×
- Materials Science 0.3×
- Dentistry 0.3×
- Physics and Astronomy 0.2×
- Veterinary 0.2×
- Engineering 0.1×
- Health Professions 0.1×
- Computer Science 0.1×
- Environmental Science 0.1×
- Economics, Econometrics and Finance 0.1×
- Agricultural and Biological Sciences 0.1×
- Psychology 0.1×
- Energy 0.1×
- Mathematics 0.0×
- Decision Sciences 0.0×
- Social Sciences 0.0×
- Chemical Engineering 0.0×
- Earth and Planetary Sciences 0.0×
- Arts and Humanities 0.0×
Who are the top researchers at Tianjin Medical University Cancer Institute and Hospital?
Ranked on the composite score, Yi Ba, Tianqiang Song and Han Liang lead among researchers whose main affiliation is Tianjin Medical University Cancer Institute and Hospital.
- 1 Yi Ba China · #11,619 worldwide 869 citations · 55 works
- 2 Tianqiang Song China · #130,666 worldwide 169 citations · 24 works
- 3 Han Liang China · #165,936 worldwide 164 citations · 23 works
- 4 Xishan Hao China · #173,199 worldwide 140 citations · 35 works
- 5 Kai Li China · #200,405 worldwide 142 citations · 27 works
- 6 Fengju Song China · #205,459 worldwide 81 citations · 28 works
- 7 Hongli Li China · #219,824 worldwide 235 citations · 59 works
- 8 Peifang Liu China · #243,498 worldwide 126 citations · 34 works
- 9 Xiong-Zhi Wu China · #289,937 worldwide 27 citations · 29 works
- 10 Yubei Huang China · #339,813 worldwide 91 citations · 17 works
Which keywords describe research at Tianjin Medical University Cancer Institute and Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Tumor Microenvironment, Chemotherapy, Immunotherapy, Gene Expression, Radiotherapy, Clinical Practice Guidelines and Metastasis.
- Treatment Guidelines
- Gene Expression Regulation
- Apoptosis
- Epigenetic Regulation
- Prognostic Markers
- Precision Medicine
- PET Imaging
- Cancer Progression
- Breast Cancer
- Ferroptosis
- Cancer Therapy
- Biomarkers
- PD-1 and PD-L1
- Cell Death
- Prognostic Factors
- Metastasis
- Radiotherapy
- Inflammation
- Immunotherapy
- Tumor Microenvironment
- Cancer
- Chemotherapy
- Gene Expression
- Oxidative Stress
- Clinical Practice Guidelines
- Targeted Therapy
- Clinical Trials
- Immune Checkpoint Blockade
- Neoadjuvant Therapy
- Survival Analysis
- Lipid Peroxidation
- GPX4
- Immunity
- Adjuvant Therapy
- Lymphoma
- Survival
- Endoscopic Resection
- Molecular Profiling
- Genomic Profiling
- Rituximab
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer247▲ 11×48 topics
- Tumor Microenvironment221▲ 29×8 topics
- Chemotherapy194▲ 16×23 topics
- Immunotherapy129▲ 11×17 topics
- Gene Expression125▲ 12×13 topics
- Inflammation117▲ 3.3×73 topics
- Oxidative Stress105▲ 3.8×48 topics
- Radiotherapy99▲ 15×11 topics
- Clinical Practice Guidelines98▲ 11×13 topics
- Metastasis95▲ 16×12 topics
- Targeted Therapy92▲ 24×5 topics
- Prognostic Factors91▲ 12×14 topics
- Clinical Trials85▲ 7.4×15 topics
- Cell Death80▲ 20×6 topics
- Immune Checkpoint Blockade79▲ 42×1 topic
- PD-1 and PD-L179▲ 42×1 topic
- Neoadjuvant Therapy77▲ 19×5 topics
- Biomarkers68▲ 5.8×14 topics
- Survival Analysis66▲ 14×6 topics
- Cancer Therapy65▲ 6.7×19 topics
- Lipid Peroxidation63▲ 36×3 topics
- Ferroptosis62▲ 48×1 topic
- GPX462▲ 48×1 topic
- Breast Cancer62▲ 15×10 topics
- Immunity59▲ 8.6×8 topics
- Cancer Progression58▲ 19×8 topics
- Adjuvant Therapy54▲ 25×2 topics
- PET Imaging51▲ 18×5 topics
- Lymphoma47▲ 17×4 topics
- Precision Medicine46▲ 5.8×7 topics
- Survival46▲ 20×4 topics
- Prognostic Markers45▲ 25×3 topics
- Endoscopic Resection45▲ 27×2 topics
- Epigenetic Regulation45▲ 12×5 topics
- Molecular Profiling43▲ 25×3 topics
- Apoptosis41▲ 7.9×19 topics
- Genomic Profiling41▲ 23×2 topics
- Gene Expression Regulation40▲ 22×3 topics
- Rituximab39▲ 15×3 topics
- Treatment Guidelines39▲ 10×5 topics
Which research topics does Tianjin Medical University Cancer Institute and Hospital publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Ferroptosis and cancer prognosis, Lung Cancer Treatments and Mutations and RNA modifications and cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 79 works
- 2 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 62 works
- 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 38 works
- 4 RNA modifications and cancer Molecular Biology 36 works
- 5 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 32 works
- 6 Lung Cancer Research Studies Oncology 30 works
- 7 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 30 works
- 8 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 30 works
- 9 Cancer-related molecular mechanisms research Cancer Research 27 works
- 10 Cancer, Hypoxia, and Metabolism Cancer Research 27 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Tianjin Medical University Cancer Institute and Hospital's research output changed?
Output in 2018–2022 was 17% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tianjin
- Tianjin University
- Nankai University
- Hebei University of Technology
- Tianjin University of Technology
- Tiangong University
- Tianjin Medical University
- Tianjin University of Science and Technology
- Civil Aviation University of China
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.